In MS patients, blood and cerebral spinal fluid (CSF) malondialdehyde (MDA) increased and blood albumin levels decreased, strengthening the clinical evidence of increased oxidative stress in MS [35]. This evidence concerns the gene ALB and myeloid sarcoma.